254 related articles for article (PubMed ID: 10484534)
1. Role of lipoprotein(a) and apolipoprotein(a) phenotype in atherogenesis: prospective results from the Bruneck study.
Kronenberg F; Kronenberg MF; Kiechl S; Trenkwalder E; Santer P; Oberhollenzer F; Egger G; Utermann G; Willeit J
Circulation; 1999 Sep; 100(11):1154-60. PubMed ID: 10484534
[TBL] [Abstract][Full Text] [Related]
2. The relation of lipoprotein[a] concentrations and apolipoprotein[a] phenotypes with asymptomatic atherosclerosis in subjects of the Atherosclerosis Risk in Communities (ARIC) Study.
Brown SA; Morrisett JD; Boerwinkle E; Hutchinson R; Patsch W
Arterioscler Thromb; 1993 Nov; 13(11):1558-66. PubMed ID: 8218095
[TBL] [Abstract][Full Text] [Related]
3. Lipoprotein(a) and asymptomatic carotid artery disease. Evidence of a prominent role in the evolution of advanced carotid plaques: the Bruneck Study.
Willeit J; Kiechl S; Santer P; Oberhollenzer F; Egger G; Jarosch E; Mair A
Stroke; 1995 Sep; 26(9):1582-7. PubMed ID: 7660402
[TBL] [Abstract][Full Text] [Related]
4. Alcohol consumption and atherosclerosis: what is the relation? Prospective results from the Bruneck Study.
Kiechl S; Willeit J; Rungger G; Egger G; Oberhollenzer F; Bonora E
Stroke; 1998 May; 29(5):900-7. PubMed ID: 9596232
[TBL] [Abstract][Full Text] [Related]
5. Lipoprotein(a) serum concentration and apolipoprotein(a) phenotype correlate with severity and presence of ischemic cerebrovascular disease.
Jürgens G; Taddei-Peters WC; Költringer P; Petek W; Chen Q; Greilberger J; Macomber PF; Butman BT; Stead AG; Ransom JH
Stroke; 1995 Oct; 26(10):1841-8. PubMed ID: 7570736
[TBL] [Abstract][Full Text] [Related]
6. Associations among serum lipoprotein(a) levels, apolipoprotein(a) phenotypes, and myocardial infarction in patients with extremely low and high levels of serum lipoprotein(a).
Saku K; Zhang B; Liu R; Shirai K; Arakawa K
Jpn Circ J; 1999 Sep; 63(9):659-65. PubMed ID: 10496479
[TBL] [Abstract][Full Text] [Related]
7. LDL-unbound apolipoprotein(a) and carotid atherosclerosis in hemodialysis patients.
Kronenberg F; Trenkwalder E; Sturm W; Kathrein H; König P; Neyer U; Gröchenig E; Utermann G; Dieplinger H
Clin Genet; 1997 Nov; 52(5):377-86. PubMed ID: 9520130
[TBL] [Abstract][Full Text] [Related]
8. Relation of Apo(a) size to carotid atherosclerosis in an elderly multiethnic population.
Paultre F; Tuck CH; Boden-Albala B; Kargman DE; Todd E; Jones J; Paik MC; Sacco RL; Berglund L
Arterioscler Thromb Vasc Biol; 2002 Jan; 22(1):141-6. PubMed ID: 11788474
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein(a) phenotypes predict the risk for carotid atherosclerosis in patients with end-stage renal disease.
Kronenberg F; Kathrein H; König P; Neyer U; Sturm W; Lhotta K; Gröchenig E; Utermann G; Dieplinger H
Arterioscler Thromb; 1994 Sep; 14(9):1405-11. PubMed ID: 8068600
[TBL] [Abstract][Full Text] [Related]
10. Oxidized phospholipids predict the presence and progression of carotid and femoral atherosclerosis and symptomatic cardiovascular disease: five-year prospective results from the Bruneck study.
Tsimikas S; Kiechl S; Willeit J; Mayr M; Miller ER; Kronenberg F; Xu Q; Bergmark C; Weger S; Oberhollenzer F; Witztum JL
J Am Coll Cardiol; 2006 Jun; 47(11):2219-28. PubMed ID: 16750687
[TBL] [Abstract][Full Text] [Related]
11. Lipoprotein(a) and apolipoprotein(a) isoforms and proteinuria in patients with moderate renal failure.
Sechi LA; Zingaro L; Catena C; Perin A; De Marchi S; Bartoli E
Kidney Int; 1999 Sep; 56(3):1049-57. PubMed ID: 10469373
[TBL] [Abstract][Full Text] [Related]
12. Lipoprotein(a) levels and apolipoprotein(a) isoforms related to life style risk factors.
Ishikawa S; Deguchi T; Hara K; Takuma S; Kayaba K; Tsutsumi A; Kario K; Igarashi M
J Epidemiol; 1999 Feb; 9(1):32-9. PubMed ID: 10098351
[TBL] [Abstract][Full Text] [Related]
13. [Study of lipoprotein (a) phenotypes in Ivorian subject].
Tiahou G; Aveynier E; Djessou P; Sess D; Cristol JP
Bull Soc Pathol Exot; 2005 Jun; 98(2):99-103. PubMed ID: 16050374
[TBL] [Abstract][Full Text] [Related]
14. Apoprotein(a) phenotypes and plasma lipoprotein(a) concentration in patients with diabetes mellitus.
Labudovic DD; Toseska KN; Alabakovska SB; B Todorova B
Clin Biochem; 2003 Oct; 36(7):545-51. PubMed ID: 14563448
[TBL] [Abstract][Full Text] [Related]
15. Distinct risk profiles of early and advanced atherosclerosis: prospective results from the Bruneck Study.
Willeit J; Kiechl S; Oberhollenzer F; Rungger G; Egger G; Bonora E; Mitterer M; Muggeo M
Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):529-37. PubMed ID: 10669653
[TBL] [Abstract][Full Text] [Related]
16. A prospective case-control study of lipoprotein(a) levels and apo(a) size and risk of coronary heart disease in Stanford Five-City Project participants.
Wild SH; Fortmann SP; Marcovina SM
Arterioscler Thromb Vasc Biol; 1997 Feb; 17(2):239-45. PubMed ID: 9081676
[TBL] [Abstract][Full Text] [Related]
17. Lipoprotein(a) serum concentrations and apolipoprotein(a) phenotypes in mild and moderate renal failure.
Kronenberg F; Kuen E; Ritz E; Junker R; König P; Kraatz G; Lhotta K; Mann JFE; Müller GA; Neyer U; Riegel W; Riegler P; Schwenger V; VON Eckardstein A
J Am Soc Nephrol; 2000 Jan; 11(1):105-115. PubMed ID: 10616846
[TBL] [Abstract][Full Text] [Related]
18. Lipoprotein(a) concentrations, apolipoprotein(a) isoforms and clinical endpoints in haemodialysis patients with type 2 diabetes mellitus: results from the 4D Study.
Kollerits B; Drechsler C; Krane V; Lamina C; März W; Dieplinger H; Ritz E; Wanner C; Kronenberg F;
Nephrol Dial Transplant; 2016 Nov; 31(11):1901-1908. PubMed ID: 26754832
[TBL] [Abstract][Full Text] [Related]
19. [Lipoprotein(a): risk factor for atherosclerotic vascular disease important to take into account in practice].
Couderc R; Maachi M
Ann Biol Clin (Paris); 1999; 57(2):157-67. PubMed ID: 10210742
[TBL] [Abstract][Full Text] [Related]
20. Association of serum lipoprotein(a) levels and apolipoprotein(a) size polymorphism with target-organ damage in arterial hypertension.
Sechi LA; Kronenberg F; De Carli S; Falleti E; Zingaro L; Catena C; Utermann G; Bartoli E
JAMA; 1997 Jun; 277(21):1689-95. PubMed ID: 9169895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
